Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2026-02-22 @ 6:45 PM
Study NCT ID:
NCT06482892
Status:
RECRUITING
Last Update Posted:
2025-04-15
First Post:
2024-06-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TP03HN106 in Patients With Critical Limb Ischemia
Sponsor:
Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TP03HN106-CLI-IIT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |